Korean J Ophthalmol.  2017 Jun;31(3):249-256. 10.3341/kjo.2016.0007.

Cycloplegic Refraction in Hyperopic Children: Effectiveness of a 0.5% Tropicamide and 0.5% Phenylephrine Addition to 1% Cyclopentolate Regimen

• Yoo SG
• Cho MJ
• Kim US
• Baek SH

• KMID: 2379881
• DOI: http://doi.org/10.3341/kjo.2016.0007

Abstract

PURPOSE
To evaluate the effectiveness of a cycloplegic regimen using 0.5% tropicamide and 0.5% phenylephrine (Tropherine, Hanmi Pharm), in addition to 1% cyclopentolate, in hyperopic children.
METHODS
The medical records of hyperopic patients below the age of 14 years who had undergone cycloplegic retinoscopy were retrospectively reviewed. Cycloplegic refractions were performed using one of two cycloplegic regimens. Regimen 1 was a Tropherine-added regimen comprising the administration of one drop of 1% cyclopentolate followed by two to three drops of Tropherine added at 15-minute intervals. Regimen 2 was a cyclopentolate-only regimen comprising the administration of three to four drops of 1% cyclopentolate at 15-minute intervals. The mean difference between noncycloplegic and cycloplegic refraction was compared between the two regimens.
RESULTS
A total of 308 eyes of 308 hyperopic children were included. The mean difference (±standard deviation) in the spherical equivalent (SE) between cycloplegic and noncycloplegic refraction was significantly larger in regimen 2 than in regimen 1, with values of +1.70 ± 1.03 diopters (D) and +1.25 ± 0.89 D, respectively (p=0.001). The SE change after cycloplegia was significantly different between the two regimens only in patients aged 5 years or younger (p=0.001), particularly in those with high hyperopia with an SE ≥5 D (p=0.005) or fully accommodative esotropia (p=0.009). There was no significant difference between the two regimens in patients older than 5 years, regardless of the presence of high hyperopia or fully accommodative esotropia.
CONCLUSIONS
The Tropherine-added regimen exerted a weaker cycloplegic effect than the cyclopentolate-only regimen, particularly in children under the age of 5 years with high hyperopia or fully accommodative esotropia. However, the difference in refraction between the two regimens was small. A Tropherine-added regimen can be effective in hyperopic children, with less associated discomfort than the instillation of cyclopentolate.

Keyword

Accommodation; Children; Cycloplegic refraction; Hyperopia; Tropherine

MeSH Terms

Child*
Cyclopentolate*
Esotropia
Humans
Hyperopia
Medical Records
Phenylephrine*
Retinoscopy
Retrospective Studies
Tropicamide*
Cyclopentolate
Phenylephrine
Tropicamide

Reference

1. Bujara K, Schulz E, Haase W. Retinoscopy under cycloplegic and non-cycloplegic conditions in children comparison of measurements of three examiners (author's transl). Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1981; 216:339–343.

2. Hiatt RL, Jerkins G. Comparison of atropine and tropicamide in esotropia. Ann Ophthalmol. 1983; 15:341–343.

3. Ingram RM, Barr A. Refraction of 1-year-old children after cycloplegia with 1% cyclopentolate: comparison with findings after atropinisation. Br J Ophthalmol. 1979; 63:348–352.

4. Rosenbaum AL, Bateman JB, Bremer DL, Liu PY. Cycloplegic refraction in esotropic children: cyclopentolate versus atropine. Ophthalmology. 1981; 88:1031–1034.

5. Fan DS, Rao SK, Ng JS, et al. Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides. Clin Exp Ophthalmol. 2004; 32:462–467.

6. Hofmeister EM, Kaupp SE, Schallhorn SC. Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients. J Cataract Refract Surg. 2005; 31:694–700.

7. Gettes BC. Tropicamide, a new cycloplegic mydriatic. Arch Ophthalmol. 1961; 65:632–635.

8. Gettes BC, Belmont O. Tropicamide: comparative cycloplegic effects. Arch Ophthalmol. 1961; 66:336–340.

9. Applebaum M, Jaanus SD. Use of diagnostic pharmaceutical agents and incidence of adverse effects. Am J Optom Physiol Opt. 1983; 60:384–388.

10. Milder B. Tropicamide as a cycloplegic agent. Arch Ophthalmol. 1961; 66:70–72.

11. Lovasik JV. Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide. Am J Optom Physiol Opt. 1986; 63:787–803.

12. Owens H, Garner LF, Yap MK, et al. Age dependence of ocular biometric measurements under cycloplegia with tropicamide and cyclopentolate. Clin Exp Optom. 1998; 81:159–162.

13. Manny RE, Hussein M, Scheiman M, et al. Tropicamide (1%): an effective cycloplegic agent for myopic children. Invest Ophthalmol Vis Sci. 2001; 42:1728–1735.

14. Proskurina OV. Cycloplegic effectiveness of cyclopentolate and tropicamide preparations compared with atropinization. Vestn Oftalmol. 2002; 118:42–45.

15. Rosenfield M, Cohen AS. Repeatability of clinical measurements of the amplitude of accommodation. Ophthalmic Physiol Opt. 1996; 16:247–249.

16. Atchison DA, Capper EJ, McCabe KL. Critical subjective measurement of amplitude of accommodation. Optom Vis Sci. 1994; 71:699–706.

17. Lin LL, Shih YF, Hsiao CH, et al. The cycloplegic effects of cyclopentolate and tropicamide on myopic children. J Ocul Pharmacol Ther. 1998; 14:331–335.

18. Egashira SM, Kish LL, Twelker JD, et al. Comparison of cyclopentolate versus tropicamide cycloplegia in children. Optom Vis Sci. 1993; 70:1019–1026.

19. Duane TD, Jaeger EA, Tasmin W, editors. Duane's foundations of clinical ophthalmology. Philadelphia: JB Lippincott;1994. p. 37.

20. Scobee RG. The nonsurgical treatment of heterotropia. Am J Ophthalmol. 1949; 32:1734–1739.

21. Anderson HA, Hentz G, Glasser A, et al. Minus-lens-stimulated accommodative amplitude decreases sigmoidally with age: a study of objectively measured accommodative amplitudes from age 3. Invest Ophthalmol Vis Sci. 2008; 49:2919–2926.

22. Kennerdell JS, Wucher FP. Cyclopentolate associated with two cases of grand mal seizure. Arch Ophthalmol. 1972; 87:634–635.

23. Khurana AK, Ahluwalia BK, Rajan C, Vohra AK. Acute psychosis associated with topical cyclopentolate hydrochloride. Am J Ophthalmol. 1988; 105:91.

24. Awan KJ. Adverse systemic reactions of topical cyclopentolate hydrochloride. Ann Ophthalmol. 1976; 8:695–698.